SpringerLink
Log in

High-throughput, sensitive and quantitative assay for the detection of BCR-ABL kinase domain mutations

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Sawyers CL . Chronic myeloid leukemia. N Engl J Med 1999; 340: 1330–1340.

    Article  CAS  PubMed  Google Scholar 

  2. Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C . Hematologic and cytogenetic responses to Imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002; 346: 645–652.

    Article  CAS  PubMed  Google Scholar 

  3. Shah PN . Loss of response to imatinib: mechanisms and management. Hematology 2005; 2005: 183–187.

    Article  Google Scholar 

  4. http://www.sequenom.com/Assets/pdfs/appnotes/Multiplexing_hME_App_Note.pdf.

  5. Hochhaus A, Kreil S, Corbin AS, Rosee PL, Muller MC, Lahaye T et al. Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. Leukemia 2002; 16: 2190–2194.

    Article  CAS  PubMed  Google Scholar 

  6. Hughes T, Deininger M, Hochhaus A, Branford S, Radich J, Kaeda J et al. Monitoring CML patients responding to treatment with tyrosine kinase inhibitors – review and recommendations for ‘harmonizing’ current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood 2006; 108: 28–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Soverini S, Martinelli G, Amabile M, Poerio A, Bianchini M, Rosti G et al. Denaturing-HPLC-based assay for detection of ABL mutations in chronic myeloid leukemia patients resistant to Imatinib. Clin Chem 2004; 50: 1205–1213.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant from the Israel Cancer Association (AV, YC). Authors contributions: AV performed the research and wrote the paper; NA designed the research; OAF performed research; MKM analyzed data; AN analyzed data; GR designed the research and analyzed data; YC designed the research and analyzed data.

Author information

Authors and Affiliations

  1. Cancer Research Center, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel

    A Vivante, N Amariglio, M Koren-Michowitz, O Ashur-Fabian, G Rechavi & Y Cohen

  2. Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

    N Amariglio, M Koren-Michowitz, A Nagler, G Rechavi & Y Cohen

  3. Division of Hematology, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel

    M Koren-Michowitz & A Nagler

  4. Department of Gynecologic Oncology, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel

    Y Cohen

Authors
  1. A Vivante
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N Amariglio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Koren-Michowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O Ashur-Fabian
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Nagler
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G Rechavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Y Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y Cohen.

Additional information

Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vivante, A., Amariglio, N., Koren-Michowitz, M. et al. High-throughput, sensitive and quantitative assay for the detection of BCR-ABL kinase domain mutations. Leukemia 21, 1318–1321 (2007). https://doi.org/10.1038/sj.leu.2404635

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404635

  • Springer Nature Limited

Search

Navigation